Mark R. Vesely, MD

Medical School (1997-2001): George Washington University, Washington, DC

Residency, Internal Medicine (2001-2004): University of Maryland School of Medicine, Baltimore, MD

Fellowship, Cardiovascular Disease (2004-2007): University of Maryland School of Medicine, Baltimore, MD

Fellowship, Interventional Cardiology (2007-2008): University of Maryland School of Medicine, Baltimore, MD 

Current Board Certifications: Cardiovascular Disease, Nuclear Cardiology and Interventional Cardiology

Dr. Vesely is an associate professor of medicine at the University of Maryland School of Medicine.  He serves as the Program Director of the Interventional Cardiology Fellowship training program and the Director of the Baltimore VA Medical Center Cardiac Catheterization Laboratory.

Dr. Vesely's clinical interests include structural and coronary heart disease, with particular focus on mitral valve disease. He is a member of the Multi-Disciplinary Mitral Valve Disease program and performs percutaneous mitral valve repair and replacement as well as balloon mitral valvuloplasty procedures.  His interests in coronary heart disease involve radial artery access techniques and hybrid revascularization, accomplished by coupling coronary stenting with minimally invasive bypass surgery.

Dr. Vesely’s research interests are focused on the development and utilization of percutaneous mitral valve techniques. He is additionally involved in personalized medicine, developing the use of patient genetic information to optimize individual medication choices (pharmacogenetics).

Dr. Vesely sees cardiology patients at the University of Maryland Cardiology Practice in Westminster, MD and with the Multi-Disciplinary Mitral Valve Disease program at the University of Maryland Medical Center in Baltimore, MD and University of Maryland St Joseph's Medical Center in Towson, MD.

Mitral Regurgitation Mitral Stenosis Structural Heart Disease Coronary Artery Disease Personalized Medicine Pharmacogenetics

Mistry N, Vesely MR. Acute Coronary Syndromes: From ED to the CCU. Cardiol Clin. 2012 Nov; 30(4):617-27

Vesely MR, Lee JD, Zimrin D, Bonatti J. Advanced Hybrid Coronary Revascularization (HCR) using Robotic Totally Endoscopic Triple Bypass Surgery and Left Main Percutaneous Intervention. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):986-7

Bonatti J, Zimrin D, Lehr EJ, Vesely MR, Kon Z, Wehman B, DeBiasi A, Hofauer B, Weidinger F, Schachner T, Bonaros N, Friedrich G. Hybrid Coronary Revascularization Using Robotic Totally Endoscopic Surgery – Perioperative Outcome and 5-Year Results. Ann Thorac Surg. 2012 Dec (94):1920-6. PMID 23103003

Shuldiner AR, Palmer K, Pakyz RE, Alestock TD, Maloney KA, O'Neill C, Bhatty S, Schub J, Overby CL, Horenstein RB, Pollin TI, Kelemen MD, Beitelshees AL, Robinson SW, Blitzer MG, McArdle PF, Brown L, Jeng LJ, Zhao RY, Ambulos N, Vesely MR. Implementation of pharmacogenetics: The University of Maryland personalized anti-platelet pharmacogenetics program. Am J Med Genet C Semin Med Genet. 2014 Mar;166(1):76. PMID 24616408

Vesely MR, Benitez RM, Robinson SW, Collins JA, Dawood MY, Gammie JS. Surgical and Transcatheter Mitral Valve Repair for Severe Chronic Mitral Regurgitation: A review of clinical indications and patient assessment. J Am Heart Assoc. 2015 Dec 11;4(12): 1-8. PMID 26656862

Puskas J, Halkos, M, DeRose JJ, Bagiella E, Miller M, Overbey J, Bonatti J, Vesely M, Sutter F, Lynch J, Kirkwood K, Shapiro T, Boudoulas K, Crestanello J, Gehrig T, Smith P, Ragosta M, Hoff S, Zhao D, Gelijns A, Szeto W, Weisz G, Argenziano M, Liberman H, Matthai W, Ascheim D. Hybrid Coronary Revascularization for the Treatment of Multi-vessel Coronary Artery Disease: A Multi-Center Observational Study. J Am Coll Cardiol. 2016 Jul 26;68(4): 356-65. PMID 27443431